RECRUITINGOBSERVATIONAL
Quantitative and Qualitative Monocytes Analysis and Their Impact on CART Cells Reponse in Multiple Myeloma
About This Trial
Tumoral micro-environment in malignant haematological diseases, notably in multiple myeloma, is active on plasma cells survival and proliferation. Monocytosis and monocytes typing are described in multiple myeloma response as factors on proliferation and cell death evasion. CART cells have improved multiple myeloma care in last 5 years, nethertheless, early relapse occur and we must identify predictor factors of better response. The aim of this study is to analyze basic level and phenotyping of monocytes before and after CART cells infusion and study their impact on multiple myeloma response
Who May Be Eligible (Plain English)
Who May Qualify:
- Patients over 18 years old
- Treated for a multiple myeloma
- CART cells treatment proposed
- Affiliated to social security system
- Agreed to participate to the study
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Patients over 18 years old
* Treated for a multiple myeloma
* CART cells treatment proposed
* Affiliated to social security system
* Agreed to participate to the study
Locations (1)
CHRU Amiens
Amiens, France